# Bank of America Corp: financial statements, quarterly

BAC · NYSE · CIK 70858 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bac.md) · [Financials](/companies/bac/financials.md) · [Filings](/companies/bac/filings.md) · [Insiders](/companies/bac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bac/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [25.2](/filings/0000070858-24-000280.md) | [26.1 d](/filings/0000070858-26-000157.md) | [25.8](/filings/0000070858-25-000200.md) | [25.4](/filings/0000070858-25-000268.md) | [25.3](/filings/0000070858-25-000405.md) | [29.3 d](/filings/0000070858-26-000157.md) | [28.2](/filings/0000070858-26-000249.md) | [27.4](/filings/0000070858-26-000394.md) | [28.1](/filings/0000070858-25-000405.md) | [31.2 d](/filings/0000070858-26-000157.md) | [30.3](/filings/0000070858-26-000249.md) | [31.6](/filings/0000070858-26-000394.md) |
| Interest expense | $bn | [19.2](/filings/0000070858-23-000272.md) | [21.7 d](/filings/0000070858-24-000122.md) | [22.3](/filings/0000070858-24-000156.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.3](/filings/0000070858-24-000280.md) | [4.4 d](/filings/0000070858-26-000157.md) | [0.6](/filings/0000070858-25-000200.md) | [0.7](/filings/0000070858-25-000268.md) | [0.4](/filings/0000070858-25-000405.md) | [4.6 d](/filings/0000070858-26-000157.md) | [1.6](/filings/0000070858-26-000249.md) | [1.5](/filings/0000070858-26-000394.md) | [1.0](/filings/0000070858-25-000405.md) | [4.9 d](/filings/0000070858-26-000157.md) | [1.8](/filings/0000070858-26-000249.md) | [2.5](/filings/0000070858-26-000394.md) |
| Net income | $bn | [7.8](/filings/0000070858-24-000280.md) | [2.9 d](/filings/0000070858-26-000157.md) | [6.7](/filings/0000070858-25-000200.md) | [6.9](/filings/0000070858-25-000268.md) | [6.9](/filings/0000070858-25-000405.md) | [6.5 d](/filings/0000070858-26-000157.md) | [7.4](/filings/0000070858-26-000249.md) | [7.2](/filings/0000070858-26-000394.md) | [8.5](/filings/0000070858-25-000405.md) | [7.5 d](/filings/0000070858-26-000157.md) | [8.6](/filings/0000070858-26-000249.md) | [9.1](/filings/0000070858-26-000394.md) |
| Diluted EPS | $ per share | [0.90](/filings/0000070858-24-000280.md) | not reported | [0.76](/filings/0000070858-25-000200.md) | [0.83](/filings/0000070858-25-000268.md) | [0.81](/filings/0000070858-25-000405.md) | not reported | [0.89](/filings/0000070858-26-000249.md) | [0.90](/filings/0000070858-26-000394.md) | [1.06](/filings/0000070858-25-000405.md) | not reported | [1.11](/filings/0000070858-26-000249.md) | [1.21](/filings/0000070858-26-000394.md) |
| Basic EPS | $ per share | [0.91](/filings/0000070858-24-000280.md) | not reported | [0.77](/filings/0000070858-25-000200.md) | [0.83](/filings/0000070858-25-000268.md) | [0.82](/filings/0000070858-25-000405.md) | not reported | [0.91](/filings/0000070858-26-000249.md) | [0.91](/filings/0000070858-26-000394.md) | [1.08](/filings/0000070858-25-000405.md) | not reported | [1.12](/filings/0000070858-26-000249.md) | [1.22](/filings/0000070858-26-000394.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [3,153](/filings/0000070858-24-000280.md) | [3,180](/filings/0000070858-25-000139.md) | [3,274](/filings/0000070858-25-000200.md) | [3,258](/filings/0000070858-25-000268.md) | [3,324](/filings/0000070858-25-000405.md) | [3,261](/filings/0000070858-26-000157.md) | [3,349](/filings/0000070858-26-000249.md) | [3,441](/filings/0000070858-26-000394.md) | [3,404](/filings/0000070858-25-000405.md) | [3,412](/filings/0000070858-26-000394.md) | [3,496](/filings/0000070858-26-000249.md) | [3,499](/filings/0000070858-26-000394.md) |
| Total liabilities | $bn | [2,866](/filings/0000070858-23-000272.md) | [2,889](/filings/0000070858-25-000139.md) | [2,980](/filings/0000070858-24-000156.md) | [2,964](/filings/0000070858-24-000208.md) | [3,028](/filings/0000070858-24-000280.md) | [2,967](/filings/0000070858-26-000157.md) | [3,054](/filings/0000070858-25-000200.md) | [3,142](/filings/0000070858-25-000268.md) | [3,100](/filings/0000070858-25-000405.md) | [3,108](/filings/0000070858-26-000394.md) | [3,196](/filings/0000070858-26-000249.md) | [3,198](/filings/0000070858-26-000394.md) |
| Long-term debt | $bn | [290](/filings/0000070858-23-000272.md) | [302](/filings/0000070858-25-000139.md) | [296](/filings/0000070858-24-000156.md) | [290](/filings/0000070858-24-000208.md) | [297](/filings/0000070858-24-000280.md) | [283](/filings/0000070858-26-000157.md) | [304](/filings/0000070858-25-000200.md) | [313](/filings/0000070858-25-000268.md) | [311](/filings/0000070858-25-000405.md) | [318](/filings/0000070858-26-000394.md) | [326](/filings/0000070858-26-000249.md) | [340](/filings/0000070858-26-000394.md) |
| Short-term borrowings | $bn | not reported | [13.1](/filings/0000070858-25-000139.md) | not reported | not reported | not reported | [24.2](/filings/0000070858-26-000157.md) | not reported | not reported | not reported | [20.4](/filings/0000070858-26-000157.md) | not reported | not reported |
| Shareholders' equity | $bn | [287](/filings/0000070858-24-000280.md) | [290](/filings/0000070858-26-000157.md) | [294](/filings/0000070858-25-000268.md) | [294](/filings/0000070858-25-000405.md) | [297](/filings/0000070858-25-000405.md) | [294](/filings/0000070858-26-000394.md) | [294](/filings/0000070858-26-000394.md) | [298](/filings/0000070858-26-000394.md) | [304](/filings/0000070858-25-000405.md) | [303](/filings/0000070858-26-000394.md) | [301](/filings/0000070858-26-000394.md) | [301](/filings/0000070858-26-000394.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $bn | [11.8 d](/filings/0000070858-24-000280.md) | [32.7 d](/filings/0000070858-26-000157.md) | [(15.5)](/filings/0000070858-25-000200.md) | [18.1 d](/filings/0000070858-25-000268.md) | [(37.3) d](/filings/0000070858-25-000405.md) | [25.9 d](/filings/0000070858-26-000157.md) | [(2.2)](/filings/0000070858-26-000249.md) | [(9.1) d](/filings/0000070858-26-000394.md) | [46.9 d](/filings/0000070858-25-000405.md) | [(22.9) d](/filings/0000070858-26-000157.md) | [41.8](/filings/0000070858-26-000249.md) | [29.0 d](/filings/0000070858-26-000394.md) |
| Dividends paid | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $bn | [1.0 d](/filings/0000070858-24-000280.md) | [0.8 d](/filings/0000070858-26-000157.md) | [2.5](/filings/0000070858-25-000200.md) | [3.5 d](/filings/0000070858-25-000268.md) | [3.5 d](/filings/0000070858-25-000405.md) | [3.5 d](/filings/0000070858-26-000157.md) | [4.5](/filings/0000070858-26-000249.md) | [5.3 d](/filings/0000070858-26-000394.md) | [5.3 d](/filings/0000070858-25-000405.md) | [6.3 d](/filings/0000070858-26-000157.md) | [7.2](/filings/0000070858-26-000249.md) | [6.0 d](/filings/0000070858-26-000394.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8,161](/filings/0000070858-23-000272.md) | [8,182](/filings/0000070858-24-000156.md) | [8,081](/filings/0000070858-24-000208.md) | [8,076](/filings/0000070858-24-000280.md) | [8,031](/filings/0000070858-25-000200.md) | [7,961](/filings/0000070858-25-000268.md) | [7,902](/filings/0000070858-25-000405.md) | [7,771](/filings/0000070858-26-000249.md) | [7,652](/filings/0000070858-26-000394.md) | [7,627](/filings/0000070858-25-000405.md) | [7,418](/filings/0000070858-26-000249.md) | [7,294](/filings/0000070858-26-000394.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 6,992,748,365 at 2026-07-30, from the cover of the [10-Q filed 2026-07-31](/filings/0000070858-26-000394.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.